Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 15569934)

1.

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.

Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Strome SE, Leibovich BC, Kwon ED.

Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17174-9. Epub 2004 Nov 29.

2.

Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.

Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED.

Cancer. 2005 Nov 15;104(10):2084-91.

3.

Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.

Thompson RH, Dong H, Kwon ED.

Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):709s-715s. Review.

4.

B7-H1 glycoprotein blockade: a novel strategy to enhance immunotherapy in patients with renal cell carcinoma.

Thompson RH, Webster WS, Cheville JC, Lohse CM, Dong H, Leibovich BC, Kuntz SM, Sengupta S, Kwon ED, Blute ML.

Urology. 2005 Nov;66(5 Suppl):10-4.

PMID:
16194701
5.

Significance of B7-H1 overexpression in kidney cancer.

Thompson RH, Kwon ED.

Clin Genitourin Cancer. 2006 Dec;5(3):206-11. Review.

PMID:
17239274
6.

B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.

Krambeck AE, Thompson RH, Dong H, Lohse CM, Park ES, Kuntz SM, Leibovich BC, Blute ML, Cheville JC, Kwon ED.

Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10391-6. Epub 2006 Jun 23.

7.

PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.

Thompson RH, Dong H, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Kwon ED.

Clin Cancer Res. 2007 Mar 15;13(6):1757-61.

8.

Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.

Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED.

Clin Cancer Res. 2007 Mar 15;13(6):1749-56.

9.

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED.

Cancer Res. 2006 Apr 1;66(7):3381-5.

10.

Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers.

Nakanishi J, Wada Y, Matsumoto K, Azuma M, Kikuchi K, Ueda S.

Cancer Immunol Immunother. 2007 Aug;56(8):1173-82. Epub 2006 Dec 22.

PMID:
17186290
11.

B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.

Konishi J, Yamazaki K, Azuma M, Kinoshita I, Dosaka-Akita H, Nishimura M.

Clin Cancer Res. 2004 Aug 1;10(15):5094-100.

12.

Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.

Okudaira K, Hokari R, Tsuzuki Y, Okada Y, Komoto S, Watanabe C, Kurihara C, Kawaguchi A, Nagao S, Azuma M, Yagita H, Miura S.

Int J Oncol. 2009 Oct;35(4):741-9.

PMID:
19724910
13.

Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.

Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, Krambeck AE, Sengupta S, Dong H, Cheville JC, Lohse CM, Krco CJ, Webster WS, Leibovich BC, Blute ML, Knutson KL, Kwon ED.

Clin Cancer Res. 2007 Apr 1;13(7):2075-81.

14.

The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.

Ghebeh H, Mohammed S, Al-Omair A, Qattan A, Lehe C, Al-Qudaihi G, Elkum N, Alshabanah M, Bin Amer S, Tulbah A, Ajarim D, Al-Tweigeri T, Dermime S.

Neoplasia. 2006 Mar;8(3):190-8.

15.

Expression of B7-H1 in inflammatory renal tubular epithelial cells.

Chen Y, Zhang J, Li J, Zou L, Zhao T, Tang Y, Wu Y.

Nephron Exp Nephrol. 2006;102(3-4):e81-92. Epub 2005 Nov 11.

PMID:
16282703
16.

Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.

Quandt D, Jasinski-Bergner S, Müller U, Schulze B, Seliger B.

J Transl Med. 2014 May 30;12:151. doi: 10.1186/1479-5876-12-151.

17.

Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma.

Karim R, Jordanova ES, Piersma SJ, Kenter GG, Chen L, Boer JM, Melief CJ, van der Burg SH.

Clin Cancer Res. 2009 Oct 15;15(20):6341-7. doi: 10.1158/1078-0432.CCR-09-1652. Epub 2009 Oct 13.

18.

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.

Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L.

Nat Med. 2002 Aug;8(8):793-800. Epub 2002 Jun 24. Erratum in: Nat Med 2002 Sep;8(9):1039.

PMID:
12091876
19.

Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1.

de Haij S, Woltman AM, Trouw LA, Bakker AC, Kamerling SW, van der Kooij SW, Chen L, Kroczek RA, Daha MR, van Kooten C.

Kidney Int. 2005 Nov;68(5):2091-102.

PMID:
16221208
20.

Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells.

Kim J, Myers AC, Chen L, Pardoll DM, Truong-Tran QA, Lane AP, McDyer JF, Fortuno L, Schleimer RP.

Am J Respir Cell Mol Biol. 2005 Sep;33(3):280-9. Epub 2005 Jun 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk